RESUMEN

Purpose:To investigate the effects of the EtOAc extract of U. longissima which is uninvestigated previously on esophagogastric cancer induced in rats with N-methyl-N-nitro-N-nitrosoguanidin (MNNG).Methods:The anticancer activity of EtOAc extract of U. longissima was examined in the esophagogastric adenocarcinoma models induced in rats with MNNG. EtOAc extract of U. longissima, 50 and 100 mg/kg oral doses were administered once daily for six months. MNNG induced differentiated and undifferentiated type adenocarcinomas in the esophageal and gastric tissues of rats.Results:EtOAc extract of U. longissima obtained from U. longissima prevented gastric and esophageal cancerogenesis induced in rats with MNNG. EtOAc extract of U. longissima did not have a lethal effect at doses of 500, 1000 and 2000 mg/kg. The prominent anticarcinogenic activity of EtOAc extract of U. longissima 50 and 100 mg/kg suggests that it is not toxic and it is selective to the cancer tissue.Conclusion:This information may shed light on clinical implementation of EtOAc extract of U. longissima in future.(AU)

Asunto(s)

RESUMEN

Abstract Purpose: To investigate the effects of the EtOAc extract of U. longissima which is uninvestigated previously on esophagogastric cancer induced in rats with N-methyl-N-nitro-N-nitrosoguanidin (MNNG). Methods: The anticancer activity of EtOAc extract of U. longissima was examined in the esophagogastric adenocarcinoma models induced in rats with MNNG. EtOAc extract of U. longissima, 50 and 100 mg/kg oral doses were administered once daily for six months. MNNG induced differentiated and undifferentiated type adenocarcinomas in the esophageal and gastric tissues of rats. Results: EtOAc extract of U. longissima obtained from U. longissima prevented gastric and esophageal cancerogenesis induced in rats with MNNG. EtOAc extract of U. longissima did not have a lethal effect at doses of 500, 1000 and 2000 mg/kg. The prominent anticarcinogenic activity of EtOAc extract of U. longissima 50 and 100 mg/kg suggests that it is not toxic and it is selective to the cancer tissue. Conclusion: This information may shed light on clinical implementation of EtOAc extract of U. longissima in future.

Asunto(s)

RESUMEN

Flexible thermoplastic resins have been used as an alternative to partially edentulous patients for decades in the USA. However, they are neither popular nor widespread in Brazil. This material represents an excellent treatment option to solve clinical problems such as compromised esthetics caused by visible metal clasps, and fall fracture of dentures made of conventional resins. Additionally, there is little researching and no controlled clinical studies about the use of flexible resins in prosthodontics. For these reasons, this study presents a case report of a dissatisfied patient treated with a conventional removable partial denture, which was replaced by a modified metal framework without metal clasps in combination with flexible resin, and a literature review about this material focusing on the dental practitioner. The study also reports how these polymers can be used, their indications, and their clinical and laboratory considerations.

As resinas termoplásticas flexíveis têm sido uma alternativa para tratamento de pacientes parcialmente desdentados disponível há décadas nos EUA. No Brasil, no entanto, ainda são pouco utilizadas e conhecidas. Este material pode representar uma excelente opção de tratamento reabilitador, para solucionar problemas tais como o aparecimento de grampos metálicos com comprometimento da estética e fratura de próteses confeccionadas com resinas convencionais devido a quedas. Além disso, pesquisas acerca desse material são escassas e não há estudos clínicos de sua utilização na área de prótese dentária na literatura. Por essas razões, este estudo apresenta um caso clínico de uma paciente insatisfeita tratada com prótese removível convencional, a qual foi substituída por uma estrutura metálica modificada sem grampos em combinação com resina, e uma revisão da literatura, com o objetivo de elaborar um apanhado de informações para o clínico sobre estes materiais, além de apresentar como estes polímeros podem ser utilizados, as suas indicações em prótese parcial removível, suas considerações clínicas e laboratoriais.

RESUMEN

This paper describes the results obtained on the preparation of films composed of linter cellulose and the corresponding acetates. The acetylation was carried out in the LiCl/DMAc solvent system. Films were prepared from a LiCl/DMAc solution of cellulose acetates (degree of substitution, DS 0.8-2.9) mixed with linter cellulose (5, 10 and 15 wt %). Detailed characterization of the films revealed the following: (i) they exhibited fibrous structures on their surfaces. The strong tendency of the linter cellulose chains to aggregate in LiCl/DMAc suggests that these fibrous elements consist of cellulose chains, as can be deduced from SEM images of the film of cellulose proper; (ii) the cellulose acetate films obtained from samples with DS 2.1 and 2.9 exhibited microspheres on the surface, whose formation seems to be favored for acetates with higher DS; (iii) AFM analysis showed that, in general, the presence of cellulose increased both the asperity thickness and the surface roughness of the analyzed films, indicating that cellulose chains are at least partially organized in domains and not molecularly dispersed between acetate chains; and (iv) the films prepared from cellulose and acetates exhibited lower hygroscopicity than the acetate films, also suggesting that the cellulose chains are organized into domains, probably due to strong intermolecular interactions. The linter and sisal acetates (the latter from a prior study), and their respective films, were prepared using the same processes; however, the two sets of films presented more differences (as in humidity absorption, optical, and tensile properties) than similarities (as in some morphological aspects), most likely due to the different properties of the starting materials. Potential applications of the films prepared in tissue engineering scaffold coatings and/or drug delivery are mentioned.